JAGSNPHARM.BOJAGSNPHARM.BO
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$549.52M
↑ 172% above average
Average (9y)
$201.98M
Historical baseline
Range
High:$549.52M
Low:$-58.21M
CAGR
+27.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $549.52M | +57.4% |
| 2024 | $349.18M | -24.6% |
| 2023 | $463.37M | +803.1% |
| 2022 | $51.31M | -81.5% |
| 2021 | $277.53M | +202.4% |
| 2020 | $91.79M | -68.0% |
| 2019 | $286.43M | +630.1% |
| 2018 | $-54.04M | +7.2% |
| 2017 | $-58.21M | -192.5% |
| 2016 | $62.90M | - |